HAEMATE

This brand name is authorized in Austria, Brazil, Cyprus, Estonia, Spain, Finland, Croatia, Israel, Netherlands, Poland, Romania, Tunisia, Turkey

Active ingredients

The drug HAEMATE contains a combination of these active pharmaceutical ingredients (APIs):

1 Human von Willebrand factor
UNII ZE22NE22F1 - VON WILLEBRAND FACTOR HUMAN

Administration of von Willebrand factor allows correction of the haemostatic abnormalities exhibited by patients who suffer from von Willebrand factor deficiency.

Read about Von Willebrand factor
2 Factor VIII (antihaemophilic factor)
UNII 5T6B772R4Q - HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX

Activated factor VIII acts as a cofactor for activated factor IX, accelerating the conversion of factor X to activated factor X (factor Xa). Haemophilia A is a sex-linked hereditary disorder of blood coagulation due to decreased levels of factor VIII:C. By replacement therapy the plasma levels of factor VIII are increased, thereby enabling a temporary correction of the factor deficiency and correction of the bleeding tendencies.

Read about Coagulation factor VIII

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B02BD06 Von Willebrand factor and coagulation factor VIII in combination B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 502600904154413, 502612020005803, 502612020005903, 502612020006003, 502621070010907, 502621070011007, 502621070011107
Country: EE Ravimiamet Identifier(s): 1843095, 1843107, 1843118
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 56867, 56868
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 149005, 149013, 149120
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 7003, 8317
Country: NL Z-Index G-Standaard Identifier(s): 14198193, 14198207, 14198215
Country: NL Z-Index G-Standaard, PRK Identifier(s): 101788, 101796, 101818
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100092329, 100092335, 100092341
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W13379001, W52389001, W52390001
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 8143101H, 8143102H, 8143103H
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8681624980064, 8681624980071

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.